The study will test whether the Proteus Sustained Behavior Change (SBC) System will help Type
2 diabetics feel more able to perform self-care activities, feel less distressed about
diabetes, and reduce mean fasting blood glucose levels. The SBC system uses ingestible and
wearable sensing devices and mobile phones to reinforce positive behaviors around medication
usage, exercise and rest.
Phase:
N/A
Details
Lead Sponsor:
Proteus Digital Health, Inc.
Treatments:
2,4-thiazolidinedione Dipeptidyl-Peptidase IV Inhibitors Glycoside Hydrolase Inhibitors Hypoglycemic Agents Metformin